Navigation

  • Skip to Content
NTNU Home

ntnu.edu

  • Studies
    • Master's programmes in English
    • For exchange students
    • PhD opportunities
    • All programmes of study
    • Courses
    • Financing
    • Language requirements
    • Application process
    • Academic calendar
    • FAQ
  • Research and innovation
    • NTNU research
    • Research excellence
    • Strategic research areas
    • Innovation resources
    • PhD opportunities
  • Life and housing
    • Student in Trondheim
    • Student in Gjøvik
    • Student in Ålesund
    • For researchers
    • Life and housing
  • About NTNU
    • Contact us
    • Faculties and departments
    • Libraries
    • International researcher support
    • Vacancies
    • About NTNU
    • Maps
  1. Employees

Språkvelger

Norsk

Bjørn Henning Grønberg

Bjørn Henning Grønberg

Professor
Department of Clinical and Molecular Medicine

bjorn.h.gronberg@ntnu.no
+4747297878 +4772826170 Kunnskapssenteret, 4. etasje, rom 424.04.001, Øya, St. Olavs Hospital
About Publications Media

About

Physician and specialist in oncology, both medical oncology and radiotherapy. Main research activity is focused on international, randomized, clinical intervention trials in lung cancer, especially small cell lung cancer (SCLC). The other main research area is translational research aiming at identifying clinically relevant predictive and prognostic biomarkers in SCLC.

Other research topics include health related quality of life and cancer in older patients.

ORCiD: 0000-0001-5744-1534

Education:

  • Medical doctor, University of Bergen, 1994

  • Specialist in Oncology, St. Olavs Hospital, Trondheim University Hospital, 2001

  • PhD in Clinical Medicine, NTNU, Norwegian University of Science and Technology, 2010

Current positions:

  • Full professor, Department of Clinical and Molecular Medicine, NTNU

  • Consultant in oncology, Cancer Clinic, St. Olav's Hospital, Trondheim university hospital (10% position)

  • Member of the Norwegian Board of Medical Experts for Patients with Life-Threatening Diseases (10% position)

  • Member of the board of the Norwegian Lung Cancer Study Group

Main research interests:

  • Lung cancer, especially small-cell lung cancer (SCLC), both medical treatment and radiotherapy.

  • Prognostic and predictive role of tissue and blood biomarkers in lung cancer patients.

  • Associations between comorbidity, frailty, functional status and treatment outcomes in cancer patients.

Main research projects:

  • Clinical role of ctDNA and miRNA analyses in lung cancer patients (https://www.ntnu.no/ikom/biopsi) funded by the Norwegian Cancer Society and The Liaison Committee for Education, Research and Innovation in Central Norway

  • Randomized trial comparing standard dose with high dose thoracic radiotherapy in limited stage small-cell lung cancer funded by the Norwegian Cancer Society and The Liaison Committee for Education, Research and Innovation in Central Norway

  • Randomized trial investigating whether adding atezolizumab after chemo-radiotherapy improves survival in limited stage small-cell lung cancer (https://www.ntnu.edu/ikom/achiles-trial) funded by the Norwegian Cancer Society and Roche

  • Randomized trial investigating whether adding thoracic radiotherapy to chemo-immunotherapy improves survival in extensive stage small-cell lung cancer funded by the Norwegian program for clinical research and AstraZeneca.

Institutional responsibilities:

  • Leader of the Cancer and palliative care research group (https://www.ntnu.no/ikom/kreftpalliasjon#/view/about) and Leader of the Translational cancer research unit (https://www.ntnu.no/ikom/transkreft) at the Department of clinical and molecular medicine, NTNU

Memberships:

  • NLCG, Norwegian Lung Cancer Study Group (nlcg.no)
  • IASCL, International Association for the Study of Lung Cancer
  • ASCO, American Society of Clinical Oncology
  • ESMO, European Society for Medical Oncology

Competencies

  • Antineoplastic Agents
  • Cancer
  • Cancer research
  • Classification of environmental status
  • Clinical cancer research
  • Lung cancer
  • Radiation Therapy

Publications

  • Chronological
  • By category
  • See all publications in Cristin

2023

  • Ottestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Dai, Hong Yan; Wahl, Sissel Gyrid Freim; Emdal, Elisabeth Fritzke. (2023) Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by <sup>18</sup>F-FDG PET/CT in early-stage non-small cell lung cancer (BMC Cancer, (2023), 23, 1, (646), 10.1186/s12885-023-11147-z). BMC Cancer
    Errata
  • Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Kirkevold, Øyvind; Halvorsen, Tarje Onsøien. (2023) Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC. Journal of Thoracic Oncology
    Academic article
  • Røyset, Inga Marie; Eriksen, Guro Falk; Saltyte Benth, Jurate; Saltvedt, Ingvild Tina; Grønberg, Bjørn Henning; Rostoft, Siri . (2023) Edmonton Frail Scale predicts mortality in older patients with cancer undergoing radiotherapy-A prospective observational study. PLOS ONE
    Academic article
  • Rakaee, Mehrdad; Andersen, S.; Giannikou, K.; Paulsen, Erna-Elise; Kilvær, Thomas Karsten; Rasmussen Busund, Lill-Tove. (2023) Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial. Annals of Oncology
    Academic article
  • Ottestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Dai, Hong Yan; Wahl, Sissel Gyrid Freim; Emdal, Elisabeth Fritzke. (2023) Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer. BMC Cancer
    Academic article

2022

  • Nøst, Therese Haugdahl; Skogholt, Anne Heidi; Urbarova, Ilona Halva; Mjelle, Robin; Paulsen, Erna-Elise; Dønnem, Tom. (2022) Increased levels of microRNA-320 in blood serum and plasma is associated with imminent and advanced lung cancer. Molecular Oncology
    Academic article
  • Graabak, Gustav; Grønberg, Bjørn Henning; Sandvei, Marie Søfteland; Nilssen, Yngvar; Halvorsen, Tarje Onsøien. (2022) Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018. JTO Clinical and Research Reports
    Academic article
  • Ottestad, Anine Larsen; Emdal, Elisabeth Fritzke; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Dai, Hong Yan. (2022) Fragmentation assessment of FFPE DNA helps in evaluating NGS library complexity and interpretation of NGS results. Experimental and molecular pathology (Print)
    Academic article
  • Eriksen, Guro Falk; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Rostoft, Siri ; Kirkevold, Øyvind; Bergh, Sverre. (2022) Cognitive Trajectories in Older Patients with Cancer Undergoing Radiotherapy—A Prospective Observational Study. Current Oncology
    Academic article
  • Kristensen, Are Korsnes; Grønberg, Bjørn Henning; Fløtten, Øystein; Kaasa, Stein; Solheim, Tora S. (2022) Trajectory of health-related quality of life during the last year of life in patients with advanced non-small–cell lung cancer. Supportive Care in Cancer
    Academic article
  • Bady, Pierre; Marosi, Christine; Weller, Michael; Grønberg, Bjørn Henning; Schultz, Henrik; Taphoorn, Martin J B. (2022) DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome-including in elderly patients. Acta neuropathologica communications
    Academic article
  • Horndalsveen, Henrik; Alver, Tine Norman; Dalsgaard, Astrid Marie; ROGG, LOTTE VICTORIA; Helbekkmo, Nina; Grønberg, Bjørn Henning. (2022) Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT-1 trial. Molecular Oncology
    Academic article
  • Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Langer, Seppo W.; Nyman, Jan. (2022) Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer. Lung Cancer
    Academic article
  • Eide, Inger Johanne; Stensgaard, Simone; Helland, Åslaug; Ekman, Simon; Mellemgaard, Anders; Hansen, Karin Holmskov. (2022) Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials. Translational Lung Cancer Research (TLCR)
    Academic article
  • Eriksen, Guro Falk; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Rostoft, Siri ; Kirkhus, Lene; Kirkevold, Øyvind. (2022) Geriatric impairments are associated with reduced quality of life and physical function in older patients with cancer receiving radiotherapy - A prospective observational study. Journal of Geriatric Oncology
    Academic article
  • Yksnøy, Øyvind; Hoff, Dag Arne Lihaug; Grønberg, Bjørn Henning; Roth, Kjetil. (2022) Proportion of mediastinal lymph nodes that cross predefined borders on the IASLC map. European Respiratory Journal
    Abstract
  • Helland, Åslaug; Russnes, Hege Elisabeth Giercksky; Fagereng, Gro Live; Al-Shibli, Khalid Ibrahim; Andersson, Yvonne; Berg, Thomas. (2022) Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway (Journal of Translational Medicine, (2022), 20, 1, (225), 10.1186/s12967-022-03432-5). Journal of Translational Medicine
    Errata
  • Stokke, Kristin; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning; Saltvedt, Ingvild; Jordhøy, Marit Slaaen; Kirkevold, Øyvind. (2022) Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC. Healthcare
    Academic article
  • Helland, Åslaug; Russnes, Hege Elisabeth Giercksky; Fagereng, Gro Live; Al-Shibli, Khalid Ibrahim; Andersson, Yvonne; Berg, Thomas. (2022) Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway. Journal of Translational Medicine
    Article in business/trade/industry journal
  • Tasken, Kjetil; Russnes, Hege Elisabeth Giercksky; Aas, Eline; Bjørge, Line; Blix, Egil Støre; Ahlquist, Terje C.. (2022) A national precision cancer medicine implementation initiative for Norway. Nature Medicine
    Letter to the editor
  • Stokke, Kristin; Sandvei, Marie Søfteland; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2022) Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer. Clinical Medicine Insights: Oncology
    Academic article

2021

  • Røyset, Inga; Saltvedt, Ingvild; Rostoft, Siri; Grønberg, Bjørn Henning; Kirkevold, Øyvind; Oldervoll, Line. (2021) Geriatric assessment with management for older patients with cancer receiving radiotherapy. Protocol of a Norwegian cluster-randomised controlled pilot study. Journal of Geriatric Oncology
    Academic article
  • Stokstad, Trine; Sørhaug, Sveinung; Amundsen, Tore; Grønberg, Bjørn Henning. (2021) Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer. In Vivo
    Academic article
  • Eide, Inger Johanne; Grut, Harald; Helland, Åslaug; Ekman, Simon; Sørensen, Jens Benn; Hansen, Karin Holmskov. (2021) Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study. Acta Oncologica
    Academic article
  • Ottestad, Anine Larsen; Hong, Yan Dai; Halvorsen, Tarje Onsøien; Emdal, Elisabeth Fritzke; Wahl, Sissel Gyrid Freim; Grønberg, Bjørn Henning. (2021) Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer. Cancer Treatment and Research Communications
    Academic article
  • Stokstad, Trine; Grønberg, Bjørn Henning. (2021) Kort utredningstid for lungekreftpasienter er ikke nødvendigvis assosiert med økt overlevelse. BestPractise Nordic oncologi/hematologi
    Article in business/trade/industry journal
  • Wahl, Sissel Gyrid Freim; Hong, Yan Dai; Emdal, Elisabeth Fritzke; Berg, Thomas; Halvorsen, Tarje Onsøien; Ottestad, Anine Larsen. (2021) The prognostic effect of KRAS mutations in non-small cell lung carcinoma revisited: A norwegian multicentre study. Cancers
    Academic article
  • Grønberg, Bjørn Henning; Langer, Seppo W.; Nyman, Jan; Halvorsen, Tarje Onsøien. (2021) Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer – Authors' reply. The Lancet Oncology
    Letter to the editor
  • Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Brustugun, Odd; HORNSLIEN, KJERSTI; Madebo, Tesfaye. (2021) High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. The Lancet Oncology
    Academic article
  • Nordgård, Oddmund; Forthun, Rakel Brendsdal; Lapin, Morten; Grønberg, Bjørn Henning; Kalland, Karl Henning; Kopperud, Reidun Kristin. (2021) Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System . Cancers
    Academic literature review
  • Wahl, Sissel Gyrid Freim; Hong, Yan Dai; Emdal, Elisabeth Fritzke; Ottestad, Anine Larsen; Dale, Vibeke Grotnes; Richardsen, Elin. (2021) Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy. The journal of pathology. Clinical research
    Academic article
  • Dunwell, Thomas L.; Dailey, Simon C.; Ottestad, Anine Larsen; Yu, Jihang; Becker, Philipp W.; Scaife, Sarah. (2021) Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA. Scientific Reports
    Academic article
  • Eriksen, Guro Falk; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Rostoft, Siri ; Kirkhus, Lene; Kirkevold, Øyvind. (2021) Geriatric impairments are prevalent and predictive of survival in older patients with cancer receiving radiotherapy: a prospective observational study. Acta Oncologica
    Academic article

2020

  • Ottestad, Anine Larsen; Wahl, Sissel Gyrid Freim; Grønberg, Bjørn Henning; Skorpen, Frank; Hong, Yan Dai. (2020) The relevance of tumor mutation profiling in interpretation of NGS data from cell-free DNA in non-small cell lung cancer patients. Experimental and molecular pathology (Print)
    Academic article
  • Kirkhus, Lene; Saltyte-Benth, Jurate; Grønberg, Bjørn Henning; Hjermstad, Marianne Jensen; Rostoft, Siri; Harneshaug, Magnus. (2020) Reply to the letter to the editor ‘Geriatric-oncology and palliative care: cautionary on using geriatric assessment as a sole basis to limit care’. Palliative Medicine
    Letter to the editor
  • Eide, Inger Johanne; Helland, Åslaug; Ekman, Simon; Mellemgaard, Anders; Hansen, Karin Holmskov; Cicenas, Saulius. (2020) Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study). Lung Cancer
    Academic article
  • Harneshaug, Magnus; Saltyte Benth, Jurate; Kirkhus, Lene; Gronberg, Bjorn Henning; Bergh, Sverre; Rostoft, Siri . (2020) CT Derived Muscle Measures, Inflammation, and Frailty in a Cohort of Older Cancer Patients. In Vivo
    Academic article
  • Grønberg, Bjørn Henning. (2020) Høydosert strålebehandling ved småcellet lungekreft i begrenset stadium. BestPractise Nordic oncologi/hematologi
    Short communication
  • Brustugun, Odd Terje; Sørhaug, Sveinung; Grønberg, Bjørn Henning; Aanerud, Marianne; Al-Zubaydi, Mohammed Modar; Fjellbirkeland, Lars. (2020) Tidsskrift for Den norske legeforening
    Feature article
  • Halvorsen, Tarje Onsøien; Stokke, Kristin; Killingberg, Kristin Toftaker; Raj, Sunil Xavier; Sørhaug, Sveinung; Brustugun, Odd Terje. (2020) Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Acta Oncologica
    Academic article
  • Sjøgren, Kristina; Jacobsen, Kristian Aalberg; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien. (2020) Timing of severe toxicity from chemotherapy in patients with lung cancer. Anticancer Research
    Academic article
  • Halvorsen, Tarje Onsøien; Valan, Christine Damgaard; Jordhøy, Marit Slaaen; Grønberg, Bjørn Henning. (2020) Associations between muscle measures, survival and toxicity in patients with limited disease small cell lung cancer. Journal of Cachexia, Sarcopenia and Muscle
    Academic article
  • Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Jordhøy, Marit Slaaen; Grønberg, Bjørn Henning. (2020) Changes in muscle measures during chemoradiotherapy in patients with limited stage small cell lung cancer. JCSM Clinical Reports
    Academic article

2019

  • Kirkhus, Lene; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Hjermstad, Marianne Jensen; Rostoft, Siri ; Harneshaug, Magnus. (2019) Frailty identified by geriatric assessment is associated with poor functioning, high symptom burden and increased risk of physical decline in older cancer patients: Prospective observational study. Palliative Medicine
    Academic article
  • Yksnøy, Øyvind; Hoff, Dag Arne Lihaug; Grønberg, Bjørn Henning; Sørhaug, Sveinung; Roth, Kjetil. (2019) Location of three mediastinal lymph node stations in a three-dimensional model. European Respiratory Journal
    Abstract
  • Pettersen, Kristine; Andersen, Sonja Benedikte; van der Veen, Anna; Nonstad, Unni; Hatakeyema, Shinji; Lambert, Christian. (2019) Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia. Journal of Cachexia, Sarcopenia and Muscle
    Academic article
  • Kirkhus, Lene; Benth, Jurate Saltyte; Grønberg, Bjørn Henning; Hjermstad, Marianne Jensen; Rostoft, Siri ; Harneshaug, Magnus. (2019) Reply to the letter to the editor 'Geriatric-oncology and palliative care: cautionary on using geriatric assessment as a sole basis to limit care'. Palliative Medicine
    Letter to the editor
  • Stokstad, Trine; Sørhaug, Sveinung; Amundsen, Tore; Grønberg, Bjørn Henning. (2019) Reasons for prolonged time for diagnostic workup for stage I-II lung cancer and estimated effect of applying an optimized pathway for diagnostic procedures. BMC Health Services Research
    Academic article
  • Kirkhus, Lene; Harneshaug, Magnus; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Rostoft, Siri ; Bergh, Sverre. (2019) Modifiable factors affecting older patients' quality of life and physical function during cancer treatment. Journal of Geriatric Oncology
    Academic article
  • Grønberg, Bjørn Henning; Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Sjøblom, Bjørg; Jordhøy, Marit Slaaen. (2019) Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients. Journal of Cachexia, Sarcopenia and Muscle
    Academic article

2018

  • Valan, Christine Damgaard; Slagsvold, Jens Erik; Halvorsen, Tarje Onsøien; Herje, Martin; Bremnes, Roy M.; Brunsvig, Paal Fr.. (2018) Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement. Anticancer Research
    Academic article
  • Berger, Ola; Grønberg, Bjørn Henning; Loge, Jon Håvard; Kaasa, Stein; Sand, Kari. (2018) Cancer patients' knowledge about their disease and treatment before, during and after treatment: a prospective, longitudinal study. BMC Cancer
    Academic article
  • Kristensen, Are Korsnes; Solheim, Tora Skeidsvoll; Fløtten, Øystein; Grønberg, Bjørn Henning. (2018) Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small-cell lung cancer: a pooled analysis of two randomized trials. Acta Oncologica
    Academic article
  • Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning. (2018) Komorbiditet ved småcellet lungekreft og begrenset utbredelse (LD SCLC). Best Practice Onkologi/Hematologi
    Article in business/trade/industry journal
  • Grønberg, Bjørn Henning; Sjøblom, Bjørg; Wentzel-Larsen, Tore; Baracos, Vickie Elaine; Hjermstad, Marianne Jensen; Aass, Nina Kathrine. (2018) A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer. European Journal of Clinical Nutrition
    Academic article
  • Lund-Iversen, Marius; Scott, Helge; Strøm, Erik Heyerdahl; Theiss, Noah; Brustugun, Odd Terje; Grønberg, Bjørn Henning. (2018) Expression of estrogen receptor-α and survival in advanced-stage non-small cell lung cancer. Anticancer Research
    Academic article
  • Harneshaug, Magnus; Kirkhus, Lene; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Bergh, Sverre; Whist, Jon Elling. (2018) Screening for frailty among older patients with cancer using blood biomarkers of inflammation. Journal of Geriatric Oncology
    Academic article
  • Brustugun, Odd Terje; Grønberg, Bjørn Henning; Fjellbirkeland, Lars; Helbekkmo, Nina; Aanerud, Marianne; Grimsrud, Tom Kristian. (2018) Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016. Lung Cancer
    Academic article

2017

  • Malmström, Annika; Poulsen, Hans Skovgaard; Grønberg, Bjørn Henning; Stragliotto, Giuseppe; Hansen, Steinbjørn; Asklund, Thomas. (2017) Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial. Acta Oncologica
    Academic article
  • Kirkhus, Lene; Saltyte Benth, Jurate; Kristjansson, Siri Rostoft; Grønberg, Bjørn Henning; Hjermstad, Marianne Jensen; Selbæk, Geir. (2017) Geriatric assessment is superior to oncologists’ clinical judgement in identifying frailty. British Journal of Cancer
    Academic article
  • Pettersen, Kristine; Andersen, Sonja Benedikte; Degen, Simone; Tadini, Valentina; Grosjean, Joël; Hatakeyama, Shinji. (2017) Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling. Scientific Reports
    Academic article
  • Stokstad, Trine; Sørhaug, Sveinung; Amundsen, Tore; Grønberg, Bjørn Henning. (2017) Medical complexity and time to lung cancer treatment - A three-year retrospective chart review. BMC Health Services Research
    Academic literature review
  • Kristensen, Are Korsnes; Solheim, Tora Skeidsvoll; Grønberg, Bjørn Henning. (2017) Best Practice Onkologi/Hematologi
    Abstract
  • Kristensen, Are Korsnes; Solheim, Tora Skeidsvoll; Amundsen, Tore; Hjelde, Harald Harris; Kaasa, Stein; Sørhaug, Sveinung. (2017) Measurement of health-related quality of life during chemotherapy -the importance of timing. Acta Oncologica
    Academic article
  • Bye, Asta; Sjøblom, Bjørg; Wentzel-Larsen, Tore; Grønberg, Bjørn Henning; Baracos, Vickie E.; Hjermstad, Marianne Jensen. (2017) Muscle mass and association to quality of life in non-small cell lung cancer patients. Journal of Cachexia, Sarcopenia and Muscle
    Academic article
  • Simmons, Claribel P.; Koinis, Filippos; Fallon, Marie T.; Fearon, Kenneth C.; Bowden, Jo; Solheim, Tora Skeidsvoll. (2017) Corrigendum to "Prognosis in advanced lung cancer ? A prospective study examining key clinicopathological factors". Lung Cancer
    Errata
  • Sjøblom, Bjørg; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Baracos, Vickie E.; Sawyer, Michael; Fløtten, Øystein. (2017) Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer. Clinical Lung Cancer
    Academic article

2016

  • Dønnem, Tom; Kilvær, Thomas Karsten; Andersen, Sigve; Richardsen, Elin; Paulsen, Erna-Elise; Hald, Sigurd. (2016) Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. Annals of Oncology
    Academic article
  • Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf. (2016) Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer. Acta Oncologica
    Academic article
  • Sundstrøm, Stein Harald; Brunsvig, Paal Fr.; Bremnes, Roy M.; Grønberg, Bjørn Henning; Brustugun, Odd Terje. (2016) Lungekreft. Universitetet i Oslo
    Chapter
  • Fløtten, Øystein; Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Helbekkmo, Nina; Bremnes, Roy M.; Plessen, Christian von. (2016) Oral versus intravenous vinorelbine in advanced NSCLC - a retrospective comparison. Cancer Treatment and Research Communications
    Academic article
  • Kirkhus, Lene; Jordhøy, Marit; Saltyte Benth, Jurate; Kristjansson, Siri Rostoft; Selbæk, Geir; Hjermstad, Marianne Jensen. (2016) Comparing comorbidity scales: Attending physician score versus the Cumulative Illness Rating Scale for Geriatrics. Journal of Geriatric Oncology
    Academic article
  • Kristensen, Are Korsnes; Vagnildhaug, Ola Magne; Grønberg, Bjørn Henning; Kaasa, Stein; Laird, Barry J; Solheim, Tora Skeidsvoll. (2016) Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. Critical Reviews in Oncology/Hematology
    Academic literature review
  • Halvorsen, Tarje Onsøien; Herje, Martin; Levin, Nina; Bremnes, Roy M.; Brustugun, Odd Terje; Fløtten, Øystein. (2016) Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer. Lung Cancer
    Academic article
  • Halvorsen, Tarje Onsøien; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf. (2016) Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer. Acta Oncologica
    Academic article
  • Sjøblom, Bjørg; Grønberg, Bjørn Henning; Wentzel-Larsen, Tore; Baracos, Vickie E.; Hjermstad, Marianne Jensen; Aass, Nina Kathrine. (2016) Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer. Clinical Nutrition
    Academic article

2015

  • Stene, Guro Birgitte; Helbostad, Jorunn L.; Amundsen, Tore; Sørhaug, Sveinung; Hjelde, Harald Harris; Kaasa, Stein. (2015) Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Acta Oncologica
    Academic article
  • Anshushaug, Malin; Gynnild, Mari Aas; Kaasa, Stein; Kvikstad, Anne; Grønberg, Bjørn H.. (2015) Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncologica
    Academic article
  • Sjøblom, Bjørg; Grønberg, Bjørn Henning; Saltyte Benth, Jurate; Baracos, Vickie E.; Fløtten, Øystein; Hjermstad, Marianne Jensen. (2015) Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer. Lung Cancer
    Academic article
  • Grønberg, Bjørn Henning; Levin, Nina; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.. (2015) Reduction in tumor size after the first course of cisplatin/etoposide (PE) in limited disease small-cell lung cancer (LD SCLC). Journal of Clinical Oncology
    Abstract
  • Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Bremnes, Roy M.. (2015) Associations between Comorbidity, Treatment Toxicity and Overall Survival in Limited Disease Small-Cell Lung Cancer (LD-SCLC). Journal of Thoracic Oncology
    Abstract
  • Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Levin, Nina; Bremnes, Roy M.; Brunsvig, Paal Fr.; Fløtten, Øystein. (2015) Survival of patients with N3 lymph node disease in a cohort with limited disease small-cell lung cancer receiving concurrent chemoradiotherapy. Journal of Thoracic Oncology
    Abstract
  • Simmons, Claribel P; Koinis, Filippos; Fallon, Marie T.; Fearon, Kenneth C.; Bowden, Jo; Solheim, Tora Skeidsvoll. (2015) Prognosis in advanced lung cancer - A prospective study examining key clinicopathological factors. Lung Cancer
    Academic article

2014

  • Berger, Ola; Sand, Kari; Johansen, Ingunn; Loge, Jon Håvard; Kaasa, Stein; Grønberg, Bjørn H.. (2014) What Do Cancer Patients and Members of Ethical Review Boards in Norway Consider Important Elements of Informed Consent Documents?. AJOB Empirical Bioethics
    Academic article
  • Grønberg, Bjørn H.; Bjørkvoll, Marte; Mathisen, Cecilie Lund. (2014) BestPractice onkologi hematologi i Norge
    Article in business/trade/industry journal
  • Grønberg, Bjørn H.; Bjørkvoll, Marte; Mathisen, Cecilie Lund; Lund, Jo-Åsmund; Kaasa, Stein. (2014) Causes for hospitalizing patients at a university hospital cancer clinic. Journal of Clinical Oncology
    Abstract
  • Slåstad, Siri; Leira, Håkon Lasse; Aas, Oddfrid; Amundsen, Tore; Sørhaug, Sveinung; Sundstrøm, Stein Harald. (2014) Tidsskrift for Den norske legeforening
    Academic article
  • Berger, Ola; Sand, Kari; Johansen, Ingunn; Loge, Jon Håvard; Kaasa, Stein; Grønberg, Bjørn Henning. (2014) What Do Cancer Patients and Members of Ethical Review Boards in Norway Consider Important Elements in Informed Consent Documents?. Palliative Medicine
    Abstract

2013

  • Grønberg, Bjørn H.; Mathisen, Cecilie Lund; Bjørkvoll, Marte. (2013) NTNU
    Thesis at a second degree level
  • Grønberg, Bjørn H.; Lund-Iversen, Marius; Strøm, Erik Heyerdahl; Brustugun, Odd Terje; Scott, Helge. (2013) Associations between TS, TTF-1, FR-alpha, FPGS, and overall survival in patients with advanced non-small-cell lung cancer receiving pemetrexed plus carboplatin or gemcitabine plus carboplatin as first-line chemotherapy. Journal of Thoracic Oncology
    Academic article
  • Grønberg, Bjørn H.; Sørhaug, Sveinung. (2013)
    Website (informational material)

2012

  • Gynnild, Mari Aas; Anshushaug, Malin; Kaasa, Stein; Kvikstad, Anne; Grønberg, Bjørn H.. (2012) Palliative cancer therapy during end of life at a regional cancer center in Norway in 2005 and 2009. Journal of Clinical Oncology
    Abstract
  • Fløtten, Øystein; Grønberg, Bjørn Henning; Bremnes, Roy M.; Amundsen, Tore; Sundstrøm, Stein Harald; Rolke, Heidi. (2012) Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group. British Journal of Cancer
    Academic article
  • Grønberg, Bjørn Henning; Ciuleanu, Tudor; Fløtten, Øystein; Knuuttila, A; Abel, Edvard; Langer, Seppo. (2012) A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer. Lung Cancer
    Academic article
  • Malmström, Annika; Grønberg, Bjørn Henning; Marosi, C; Stupp, R; Frappaz, D; Schultz, Henrik. (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. The Lancet Oncology
    Academic article
  • Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf. (2012) Randomized phase II trial comparing two schedules of thoracic radiotherapy (TRT) in limited disease small-cell lung cancer (LD SCLC). Journal of Clinical Oncology
    Abstract
  • Brustugun, Odd Terje; Helland, Åslaug; Fjellbirkeland, Lars; Kleinberg, Lilach; Ariansen, Sarah Louise; Jebsen, Peter Wilhelm. (2012) Mutasjonstesting ved ikke-småcellet lungekreft. Tidsskrift for Den norske legeforening
    Academic article

2011

  • Grønberg, Bjørn Henning; Lund-Iversen, Marius; Strøm, Erik Heyerdahl; Brustugun, Odd Terje; Scott, Helge. (2011) Associations between biomarkers and outcomes of first-line chemotherapy in advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology
    Abstract
  • Grønberg, Bjørn Henning; Ciuleanu, Tudor; Fløtten, Øystein; Knuutila, Aija; Abel, Edvard; Langer, Seppo. (2011) Randomized Phase Study of Maintenance Enzastaurin Following Whole Brain Radiation Therapy in the Treatment of Brain Metastases from Lung Cancer: The MENZA Study. European Journal of Cancer
    Abstract
  • Hatlen, Peter; Grønberg, Bjørn H.; Langhammer, Arnulf; Carlsen, Sven Magnus; Amundsen, Tore. (2011) Prolonged Survival in Patients with Lung Cancer with Diabetes Mellitus. Journal of Thoracic Oncology
    Academic article

2010

  • Grønberg, Bjørn H.; Sundstrøm, Stein; Kaasa, Stein; Bremnes, Roy M.; Fløtten, Øystein; Amundsen, Tore. (2010) Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. European Journal of Cancer
    Academic article
  • Grønberg, Bjørn H.. (2010) Pemetrexed in the treatment of advanced lung cancer. Tapir Akademisk Forlag Tapir Akademisk Forlag
    Doctoral dissertation
  • Grønberg, Bjørn H.. (2010) ASCO Home Meetings Abstracts 2010 ASCO Annual Meeting Phase III study comparing vinorelbine/gemcitabine with vinorelbine/carboplatin as first-line chemotherapy of advanced NSCLC: A Norwegian Lung Cancer Study Group trial. Journal of Clinical Oncology
    Abstract
  • Grønberg, Bjørn H.. (2010) Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ). Journal of Clinical Oncology
    Abstract
  • Malmström, Annika; Poulsen, Hans Skovgaard; Stragliotto, G.; Grønberg, Bjørn H.; Hansen, S.; Asklund, Thomas. (2010) NEOADJUVANT TEMOZOLOMIDE FOR GRADE III AND IV ATROCYTOMA: A RANDOMIZED PHASE II STUDY. Neuro-Oncology
    Abstract
  • Malmström, Annika; Grønberg, Bjørn H.; Stupp, Roger; Marosi, Christine; Frappaz, Didier; Schultz, Henrik. (2010) GLIOBLASTOMA IN ELDERLY PATIENTS: HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN A RANDOMIZED TRIAL COMPARING 6-WEEKS OF RADIOTHERAPY (RT) VS HYPOFRACTIONATED RT OVER 2 WEEKS VS TEMOZOLOMIDE CHEMOTHERAPY (TMZ). Neuro-Oncology
    Abstract

2009

  • Grønberg, BH; Bremnes, Roy M.; Aasebø, Ulf; Brunsvig, Paal; Fløtten, Øystein; Amundsen, T. (2009) A prospective phase II study: High-dose pemetrexed as second-line chemotherapy in small-cell lung cancer. Lung Cancer
    Academic article
  • Berger, Ola; Grønberg, Bjørn H.; Sand, Kari; Kaasa, Stein; Loge, Jon Håvard. (2009) The length of consent documents in oncological trials is doubled in twenty years. Annals of Oncology
    Academic article
  • Brunsvig, PF; Sundstrom, S; Aasebo, U; Bremnes, R; Hansen, O; Helle, SI. (2009) A phase III study of radiation therapy with concurrent docetaxel versus radiation therapy alone in patients with non-small cell lung cancer stage IIIA/B. Journal of Thoracic Oncology
    Abstract
  • Grønberg, BH; Gronberg, Bjørn H.; Bremnes, Roy M.; Fløtten, Øystein; Amundsen, T; Amundsen, Tore. (2009) Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology
    Academic article

2008

  • Sand, Kari; Loge, Jon Håvard; Berger, Ola; Grønberg, Bjørn H.; Kaasa, Stein. (2008) Lung cancer patients' perceptions of informed consent documents. Patient Education and Counseling
    Academic article

2007

  • Grønberg, Bjørn H.. (2007) Pemetrexed + carboplatin versus gemcitabine + carboplatin in the treatment of stage IIIB/IV non-small cell lung cancer. Journal of Clinical Oncology
    Abstract
  • Grønberg, Bjørn H.. (2007) A phase III study by the Norwegian Lung Cancer Group: Pemetrexed plus carboplatin vs. gemcitabine plus carboplatin as firstline chemotherapy in stage IIIB/IV non-small cell lung cancer. Journal of Thoracic Oncology
    Abstract

Journal publications

  • Ottestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Dai, Hong Yan; Wahl, Sissel Gyrid Freim; Emdal, Elisabeth Fritzke. (2023) Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by <sup>18</sup>F-FDG PET/CT in early-stage non-small cell lung cancer (BMC Cancer, (2023), 23, 1, (646), 10.1186/s12885-023-11147-z). BMC Cancer
    Errata
  • Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Kirkevold, Øyvind; Halvorsen, Tarje Onsøien. (2023) Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC. Journal of Thoracic Oncology
    Academic article
  • Røyset, Inga Marie; Eriksen, Guro Falk; Saltyte Benth, Jurate; Saltvedt, Ingvild Tina; Grønberg, Bjørn Henning; Rostoft, Siri . (2023) Edmonton Frail Scale predicts mortality in older patients with cancer undergoing radiotherapy-A prospective observational study. PLOS ONE
    Academic article
  • Rakaee, Mehrdad; Andersen, S.; Giannikou, K.; Paulsen, Erna-Elise; Kilvær, Thomas Karsten; Rasmussen Busund, Lill-Tove. (2023) Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial. Annals of Oncology
    Academic article
  • Ottestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Dai, Hong Yan; Wahl, Sissel Gyrid Freim; Emdal, Elisabeth Fritzke. (2023) Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer. BMC Cancer
    Academic article
  • Nøst, Therese Haugdahl; Skogholt, Anne Heidi; Urbarova, Ilona Halva; Mjelle, Robin; Paulsen, Erna-Elise; Dønnem, Tom. (2022) Increased levels of microRNA-320 in blood serum and plasma is associated with imminent and advanced lung cancer. Molecular Oncology
    Academic article
  • Graabak, Gustav; Grønberg, Bjørn Henning; Sandvei, Marie Søfteland; Nilssen, Yngvar; Halvorsen, Tarje Onsøien. (2022) Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018. JTO Clinical and Research Reports
    Academic article
  • Ottestad, Anine Larsen; Emdal, Elisabeth Fritzke; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Dai, Hong Yan. (2022) Fragmentation assessment of FFPE DNA helps in evaluating NGS library complexity and interpretation of NGS results. Experimental and molecular pathology (Print)
    Academic article
  • Eriksen, Guro Falk; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Rostoft, Siri ; Kirkevold, Øyvind; Bergh, Sverre. (2022) Cognitive Trajectories in Older Patients with Cancer Undergoing Radiotherapy—A Prospective Observational Study. Current Oncology
    Academic article
  • Kristensen, Are Korsnes; Grønberg, Bjørn Henning; Fløtten, Øystein; Kaasa, Stein; Solheim, Tora S. (2022) Trajectory of health-related quality of life during the last year of life in patients with advanced non-small–cell lung cancer. Supportive Care in Cancer
    Academic article
  • Bady, Pierre; Marosi, Christine; Weller, Michael; Grønberg, Bjørn Henning; Schultz, Henrik; Taphoorn, Martin J B. (2022) DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome-including in elderly patients. Acta neuropathologica communications
    Academic article
  • Horndalsveen, Henrik; Alver, Tine Norman; Dalsgaard, Astrid Marie; ROGG, LOTTE VICTORIA; Helbekkmo, Nina; Grønberg, Bjørn Henning. (2022) Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT-1 trial. Molecular Oncology
    Academic article
  • Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Langer, Seppo W.; Nyman, Jan. (2022) Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer. Lung Cancer
    Academic article
  • Eide, Inger Johanne; Stensgaard, Simone; Helland, Åslaug; Ekman, Simon; Mellemgaard, Anders; Hansen, Karin Holmskov. (2022) Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials. Translational Lung Cancer Research (TLCR)
    Academic article
  • Eriksen, Guro Falk; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Rostoft, Siri ; Kirkhus, Lene; Kirkevold, Øyvind. (2022) Geriatric impairments are associated with reduced quality of life and physical function in older patients with cancer receiving radiotherapy - A prospective observational study. Journal of Geriatric Oncology
    Academic article
  • Yksnøy, Øyvind; Hoff, Dag Arne Lihaug; Grønberg, Bjørn Henning; Roth, Kjetil. (2022) Proportion of mediastinal lymph nodes that cross predefined borders on the IASLC map. European Respiratory Journal
    Abstract
  • Helland, Åslaug; Russnes, Hege Elisabeth Giercksky; Fagereng, Gro Live; Al-Shibli, Khalid Ibrahim; Andersson, Yvonne; Berg, Thomas. (2022) Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway (Journal of Translational Medicine, (2022), 20, 1, (225), 10.1186/s12967-022-03432-5). Journal of Translational Medicine
    Errata
  • Stokke, Kristin; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning; Saltvedt, Ingvild; Jordhøy, Marit Slaaen; Kirkevold, Øyvind. (2022) Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC. Healthcare
    Academic article
  • Helland, Åslaug; Russnes, Hege Elisabeth Giercksky; Fagereng, Gro Live; Al-Shibli, Khalid Ibrahim; Andersson, Yvonne; Berg, Thomas. (2022) Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway. Journal of Translational Medicine
    Article in business/trade/industry journal
  • Tasken, Kjetil; Russnes, Hege Elisabeth Giercksky; Aas, Eline; Bjørge, Line; Blix, Egil Støre; Ahlquist, Terje C.. (2022) A national precision cancer medicine implementation initiative for Norway. Nature Medicine
    Letter to the editor
  • Stokke, Kristin; Sandvei, Marie Søfteland; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2022) Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer. Clinical Medicine Insights: Oncology
    Academic article
  • Røyset, Inga; Saltvedt, Ingvild; Rostoft, Siri; Grønberg, Bjørn Henning; Kirkevold, Øyvind; Oldervoll, Line. (2021) Geriatric assessment with management for older patients with cancer receiving radiotherapy. Protocol of a Norwegian cluster-randomised controlled pilot study. Journal of Geriatric Oncology
    Academic article
  • Stokstad, Trine; Sørhaug, Sveinung; Amundsen, Tore; Grønberg, Bjørn Henning. (2021) Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer. In Vivo
    Academic article
  • Eide, Inger Johanne; Grut, Harald; Helland, Åslaug; Ekman, Simon; Sørensen, Jens Benn; Hansen, Karin Holmskov. (2021) Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study. Acta Oncologica
    Academic article
  • Ottestad, Anine Larsen; Hong, Yan Dai; Halvorsen, Tarje Onsøien; Emdal, Elisabeth Fritzke; Wahl, Sissel Gyrid Freim; Grønberg, Bjørn Henning. (2021) Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer. Cancer Treatment and Research Communications
    Academic article
  • Stokstad, Trine; Grønberg, Bjørn Henning. (2021) Kort utredningstid for lungekreftpasienter er ikke nødvendigvis assosiert med økt overlevelse. BestPractise Nordic oncologi/hematologi
    Article in business/trade/industry journal
  • Wahl, Sissel Gyrid Freim; Hong, Yan Dai; Emdal, Elisabeth Fritzke; Berg, Thomas; Halvorsen, Tarje Onsøien; Ottestad, Anine Larsen. (2021) The prognostic effect of KRAS mutations in non-small cell lung carcinoma revisited: A norwegian multicentre study. Cancers
    Academic article
  • Grønberg, Bjørn Henning; Langer, Seppo W.; Nyman, Jan; Halvorsen, Tarje Onsøien. (2021) Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer – Authors' reply. The Lancet Oncology
    Letter to the editor
  • Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Brustugun, Odd; HORNSLIEN, KJERSTI; Madebo, Tesfaye. (2021) High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. The Lancet Oncology
    Academic article
  • Nordgård, Oddmund; Forthun, Rakel Brendsdal; Lapin, Morten; Grønberg, Bjørn Henning; Kalland, Karl Henning; Kopperud, Reidun Kristin. (2021) Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System . Cancers
    Academic literature review
  • Wahl, Sissel Gyrid Freim; Hong, Yan Dai; Emdal, Elisabeth Fritzke; Ottestad, Anine Larsen; Dale, Vibeke Grotnes; Richardsen, Elin. (2021) Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy. The journal of pathology. Clinical research
    Academic article
  • Dunwell, Thomas L.; Dailey, Simon C.; Ottestad, Anine Larsen; Yu, Jihang; Becker, Philipp W.; Scaife, Sarah. (2021) Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA. Scientific Reports
    Academic article
  • Eriksen, Guro Falk; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Rostoft, Siri ; Kirkhus, Lene; Kirkevold, Øyvind. (2021) Geriatric impairments are prevalent and predictive of survival in older patients with cancer receiving radiotherapy: a prospective observational study. Acta Oncologica
    Academic article
  • Ottestad, Anine Larsen; Wahl, Sissel Gyrid Freim; Grønberg, Bjørn Henning; Skorpen, Frank; Hong, Yan Dai. (2020) The relevance of tumor mutation profiling in interpretation of NGS data from cell-free DNA in non-small cell lung cancer patients. Experimental and molecular pathology (Print)
    Academic article
  • Kirkhus, Lene; Saltyte-Benth, Jurate; Grønberg, Bjørn Henning; Hjermstad, Marianne Jensen; Rostoft, Siri; Harneshaug, Magnus. (2020) Reply to the letter to the editor ‘Geriatric-oncology and palliative care: cautionary on using geriatric assessment as a sole basis to limit care’. Palliative Medicine
    Letter to the editor
  • Eide, Inger Johanne; Helland, Åslaug; Ekman, Simon; Mellemgaard, Anders; Hansen, Karin Holmskov; Cicenas, Saulius. (2020) Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study). Lung Cancer
    Academic article
  • Harneshaug, Magnus; Saltyte Benth, Jurate; Kirkhus, Lene; Gronberg, Bjorn Henning; Bergh, Sverre; Rostoft, Siri . (2020) CT Derived Muscle Measures, Inflammation, and Frailty in a Cohort of Older Cancer Patients. In Vivo
    Academic article
  • Grønberg, Bjørn Henning. (2020) Høydosert strålebehandling ved småcellet lungekreft i begrenset stadium. BestPractise Nordic oncologi/hematologi
    Short communication
  • Brustugun, Odd Terje; Sørhaug, Sveinung; Grønberg, Bjørn Henning; Aanerud, Marianne; Al-Zubaydi, Mohammed Modar; Fjellbirkeland, Lars. (2020) Tidsskrift for Den norske legeforening
    Feature article
  • Halvorsen, Tarje Onsøien; Stokke, Kristin; Killingberg, Kristin Toftaker; Raj, Sunil Xavier; Sørhaug, Sveinung; Brustugun, Odd Terje. (2020) Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Acta Oncologica
    Academic article
  • Sjøgren, Kristina; Jacobsen, Kristian Aalberg; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien. (2020) Timing of severe toxicity from chemotherapy in patients with lung cancer. Anticancer Research
    Academic article
  • Halvorsen, Tarje Onsøien; Valan, Christine Damgaard; Jordhøy, Marit Slaaen; Grønberg, Bjørn Henning. (2020) Associations between muscle measures, survival and toxicity in patients with limited disease small cell lung cancer. Journal of Cachexia, Sarcopenia and Muscle
    Academic article
  • Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Jordhøy, Marit Slaaen; Grønberg, Bjørn Henning. (2020) Changes in muscle measures during chemoradiotherapy in patients with limited stage small cell lung cancer. JCSM Clinical Reports
    Academic article
  • Kirkhus, Lene; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Hjermstad, Marianne Jensen; Rostoft, Siri ; Harneshaug, Magnus. (2019) Frailty identified by geriatric assessment is associated with poor functioning, high symptom burden and increased risk of physical decline in older cancer patients: Prospective observational study. Palliative Medicine
    Academic article
  • Yksnøy, Øyvind; Hoff, Dag Arne Lihaug; Grønberg, Bjørn Henning; Sørhaug, Sveinung; Roth, Kjetil. (2019) Location of three mediastinal lymph node stations in a three-dimensional model. European Respiratory Journal
    Abstract
  • Pettersen, Kristine; Andersen, Sonja Benedikte; van der Veen, Anna; Nonstad, Unni; Hatakeyema, Shinji; Lambert, Christian. (2019) Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia. Journal of Cachexia, Sarcopenia and Muscle
    Academic article
  • Kirkhus, Lene; Benth, Jurate Saltyte; Grønberg, Bjørn Henning; Hjermstad, Marianne Jensen; Rostoft, Siri ; Harneshaug, Magnus. (2019) Reply to the letter to the editor 'Geriatric-oncology and palliative care: cautionary on using geriatric assessment as a sole basis to limit care'. Palliative Medicine
    Letter to the editor
  • Stokstad, Trine; Sørhaug, Sveinung; Amundsen, Tore; Grønberg, Bjørn Henning. (2019) Reasons for prolonged time for diagnostic workup for stage I-II lung cancer and estimated effect of applying an optimized pathway for diagnostic procedures. BMC Health Services Research
    Academic article
  • Kirkhus, Lene; Harneshaug, Magnus; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Rostoft, Siri ; Bergh, Sverre. (2019) Modifiable factors affecting older patients' quality of life and physical function during cancer treatment. Journal of Geriatric Oncology
    Academic article
  • Grønberg, Bjørn Henning; Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Sjøblom, Bjørg; Jordhøy, Marit Slaaen. (2019) Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients. Journal of Cachexia, Sarcopenia and Muscle
    Academic article
  • Valan, Christine Damgaard; Slagsvold, Jens Erik; Halvorsen, Tarje Onsøien; Herje, Martin; Bremnes, Roy M.; Brunsvig, Paal Fr.. (2018) Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement. Anticancer Research
    Academic article
  • Berger, Ola; Grønberg, Bjørn Henning; Loge, Jon Håvard; Kaasa, Stein; Sand, Kari. (2018) Cancer patients' knowledge about their disease and treatment before, during and after treatment: a prospective, longitudinal study. BMC Cancer
    Academic article
  • Kristensen, Are Korsnes; Solheim, Tora Skeidsvoll; Fløtten, Øystein; Grønberg, Bjørn Henning. (2018) Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small-cell lung cancer: a pooled analysis of two randomized trials. Acta Oncologica
    Academic article
  • Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning. (2018) Komorbiditet ved småcellet lungekreft og begrenset utbredelse (LD SCLC). Best Practice Onkologi/Hematologi
    Article in business/trade/industry journal
  • Grønberg, Bjørn Henning; Sjøblom, Bjørg; Wentzel-Larsen, Tore; Baracos, Vickie Elaine; Hjermstad, Marianne Jensen; Aass, Nina Kathrine. (2018) A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer. European Journal of Clinical Nutrition
    Academic article
  • Lund-Iversen, Marius; Scott, Helge; Strøm, Erik Heyerdahl; Theiss, Noah; Brustugun, Odd Terje; Grønberg, Bjørn Henning. (2018) Expression of estrogen receptor-α and survival in advanced-stage non-small cell lung cancer. Anticancer Research
    Academic article
  • Harneshaug, Magnus; Kirkhus, Lene; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Bergh, Sverre; Whist, Jon Elling. (2018) Screening for frailty among older patients with cancer using blood biomarkers of inflammation. Journal of Geriatric Oncology
    Academic article
  • Brustugun, Odd Terje; Grønberg, Bjørn Henning; Fjellbirkeland, Lars; Helbekkmo, Nina; Aanerud, Marianne; Grimsrud, Tom Kristian. (2018) Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016. Lung Cancer
    Academic article
  • Malmström, Annika; Poulsen, Hans Skovgaard; Grønberg, Bjørn Henning; Stragliotto, Giuseppe; Hansen, Steinbjørn; Asklund, Thomas. (2017) Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial. Acta Oncologica
    Academic article
  • Kirkhus, Lene; Saltyte Benth, Jurate; Kristjansson, Siri Rostoft; Grønberg, Bjørn Henning; Hjermstad, Marianne Jensen; Selbæk, Geir. (2017) Geriatric assessment is superior to oncologists’ clinical judgement in identifying frailty. British Journal of Cancer
    Academic article
  • Pettersen, Kristine; Andersen, Sonja Benedikte; Degen, Simone; Tadini, Valentina; Grosjean, Joël; Hatakeyama, Shinji. (2017) Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling. Scientific Reports
    Academic article
  • Stokstad, Trine; Sørhaug, Sveinung; Amundsen, Tore; Grønberg, Bjørn Henning. (2017) Medical complexity and time to lung cancer treatment - A three-year retrospective chart review. BMC Health Services Research
    Academic literature review
  • Kristensen, Are Korsnes; Solheim, Tora Skeidsvoll; Grønberg, Bjørn Henning. (2017) Best Practice Onkologi/Hematologi
    Abstract
  • Kristensen, Are Korsnes; Solheim, Tora Skeidsvoll; Amundsen, Tore; Hjelde, Harald Harris; Kaasa, Stein; Sørhaug, Sveinung. (2017) Measurement of health-related quality of life during chemotherapy -the importance of timing. Acta Oncologica
    Academic article
  • Bye, Asta; Sjøblom, Bjørg; Wentzel-Larsen, Tore; Grønberg, Bjørn Henning; Baracos, Vickie E.; Hjermstad, Marianne Jensen. (2017) Muscle mass and association to quality of life in non-small cell lung cancer patients. Journal of Cachexia, Sarcopenia and Muscle
    Academic article
  • Simmons, Claribel P.; Koinis, Filippos; Fallon, Marie T.; Fearon, Kenneth C.; Bowden, Jo; Solheim, Tora Skeidsvoll. (2017) Corrigendum to "Prognosis in advanced lung cancer ? A prospective study examining key clinicopathological factors". Lung Cancer
    Errata
  • Sjøblom, Bjørg; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Baracos, Vickie E.; Sawyer, Michael; Fløtten, Øystein. (2017) Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer. Clinical Lung Cancer
    Academic article
  • Dønnem, Tom; Kilvær, Thomas Karsten; Andersen, Sigve; Richardsen, Elin; Paulsen, Erna-Elise; Hald, Sigurd. (2016) Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. Annals of Oncology
    Academic article
  • Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf. (2016) Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer. Acta Oncologica
    Academic article
  • Fløtten, Øystein; Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Helbekkmo, Nina; Bremnes, Roy M.; Plessen, Christian von. (2016) Oral versus intravenous vinorelbine in advanced NSCLC - a retrospective comparison. Cancer Treatment and Research Communications
    Academic article
  • Kirkhus, Lene; Jordhøy, Marit; Saltyte Benth, Jurate; Kristjansson, Siri Rostoft; Selbæk, Geir; Hjermstad, Marianne Jensen. (2016) Comparing comorbidity scales: Attending physician score versus the Cumulative Illness Rating Scale for Geriatrics. Journal of Geriatric Oncology
    Academic article
  • Kristensen, Are Korsnes; Vagnildhaug, Ola Magne; Grønberg, Bjørn Henning; Kaasa, Stein; Laird, Barry J; Solheim, Tora Skeidsvoll. (2016) Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. Critical Reviews in Oncology/Hematology
    Academic literature review
  • Halvorsen, Tarje Onsøien; Herje, Martin; Levin, Nina; Bremnes, Roy M.; Brustugun, Odd Terje; Fløtten, Øystein. (2016) Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer. Lung Cancer
    Academic article
  • Halvorsen, Tarje Onsøien; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf. (2016) Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer. Acta Oncologica
    Academic article
  • Sjøblom, Bjørg; Grønberg, Bjørn Henning; Wentzel-Larsen, Tore; Baracos, Vickie E.; Hjermstad, Marianne Jensen; Aass, Nina Kathrine. (2016) Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer. Clinical Nutrition
    Academic article
  • Stene, Guro Birgitte; Helbostad, Jorunn L.; Amundsen, Tore; Sørhaug, Sveinung; Hjelde, Harald Harris; Kaasa, Stein. (2015) Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Acta Oncologica
    Academic article
  • Anshushaug, Malin; Gynnild, Mari Aas; Kaasa, Stein; Kvikstad, Anne; Grønberg, Bjørn H.. (2015) Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncologica
    Academic article
  • Sjøblom, Bjørg; Grønberg, Bjørn Henning; Saltyte Benth, Jurate; Baracos, Vickie E.; Fløtten, Øystein; Hjermstad, Marianne Jensen. (2015) Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer. Lung Cancer
    Academic article
  • Grønberg, Bjørn Henning; Levin, Nina; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.. (2015) Reduction in tumor size after the first course of cisplatin/etoposide (PE) in limited disease small-cell lung cancer (LD SCLC). Journal of Clinical Oncology
    Abstract
  • Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Bremnes, Roy M.. (2015) Associations between Comorbidity, Treatment Toxicity and Overall Survival in Limited Disease Small-Cell Lung Cancer (LD-SCLC). Journal of Thoracic Oncology
    Abstract
  • Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Levin, Nina; Bremnes, Roy M.; Brunsvig, Paal Fr.; Fløtten, Øystein. (2015) Survival of patients with N3 lymph node disease in a cohort with limited disease small-cell lung cancer receiving concurrent chemoradiotherapy. Journal of Thoracic Oncology
    Abstract
  • Simmons, Claribel P; Koinis, Filippos; Fallon, Marie T.; Fearon, Kenneth C.; Bowden, Jo; Solheim, Tora Skeidsvoll. (2015) Prognosis in advanced lung cancer - A prospective study examining key clinicopathological factors. Lung Cancer
    Academic article
  • Berger, Ola; Sand, Kari; Johansen, Ingunn; Loge, Jon Håvard; Kaasa, Stein; Grønberg, Bjørn H.. (2014) What Do Cancer Patients and Members of Ethical Review Boards in Norway Consider Important Elements of Informed Consent Documents?. AJOB Empirical Bioethics
    Academic article
  • Grønberg, Bjørn H.; Bjørkvoll, Marte; Mathisen, Cecilie Lund. (2014) BestPractice onkologi hematologi i Norge
    Article in business/trade/industry journal
  • Grønberg, Bjørn H.; Bjørkvoll, Marte; Mathisen, Cecilie Lund; Lund, Jo-Åsmund; Kaasa, Stein. (2014) Causes for hospitalizing patients at a university hospital cancer clinic. Journal of Clinical Oncology
    Abstract
  • Slåstad, Siri; Leira, Håkon Lasse; Aas, Oddfrid; Amundsen, Tore; Sørhaug, Sveinung; Sundstrøm, Stein Harald. (2014) Tidsskrift for Den norske legeforening
    Academic article
  • Berger, Ola; Sand, Kari; Johansen, Ingunn; Loge, Jon Håvard; Kaasa, Stein; Grønberg, Bjørn Henning. (2014) What Do Cancer Patients and Members of Ethical Review Boards in Norway Consider Important Elements in Informed Consent Documents?. Palliative Medicine
    Abstract
  • Grønberg, Bjørn H.; Lund-Iversen, Marius; Strøm, Erik Heyerdahl; Brustugun, Odd Terje; Scott, Helge. (2013) Associations between TS, TTF-1, FR-alpha, FPGS, and overall survival in patients with advanced non-small-cell lung cancer receiving pemetrexed plus carboplatin or gemcitabine plus carboplatin as first-line chemotherapy. Journal of Thoracic Oncology
    Academic article
  • Gynnild, Mari Aas; Anshushaug, Malin; Kaasa, Stein; Kvikstad, Anne; Grønberg, Bjørn H.. (2012) Palliative cancer therapy during end of life at a regional cancer center in Norway in 2005 and 2009. Journal of Clinical Oncology
    Abstract
  • Fløtten, Øystein; Grønberg, Bjørn Henning; Bremnes, Roy M.; Amundsen, Tore; Sundstrøm, Stein Harald; Rolke, Heidi. (2012) Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group. British Journal of Cancer
    Academic article
  • Grønberg, Bjørn Henning; Ciuleanu, Tudor; Fløtten, Øystein; Knuuttila, A; Abel, Edvard; Langer, Seppo. (2012) A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer. Lung Cancer
    Academic article
  • Malmström, Annika; Grønberg, Bjørn Henning; Marosi, C; Stupp, R; Frappaz, D; Schultz, Henrik. (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. The Lancet Oncology
    Academic article
  • Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf. (2012) Randomized phase II trial comparing two schedules of thoracic radiotherapy (TRT) in limited disease small-cell lung cancer (LD SCLC). Journal of Clinical Oncology
    Abstract
  • Brustugun, Odd Terje; Helland, Åslaug; Fjellbirkeland, Lars; Kleinberg, Lilach; Ariansen, Sarah Louise; Jebsen, Peter Wilhelm. (2012) Mutasjonstesting ved ikke-småcellet lungekreft. Tidsskrift for Den norske legeforening
    Academic article
  • Grønberg, Bjørn Henning; Lund-Iversen, Marius; Strøm, Erik Heyerdahl; Brustugun, Odd Terje; Scott, Helge. (2011) Associations between biomarkers and outcomes of first-line chemotherapy in advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology
    Abstract
  • Grønberg, Bjørn Henning; Ciuleanu, Tudor; Fløtten, Øystein; Knuutila, Aija; Abel, Edvard; Langer, Seppo. (2011) Randomized Phase Study of Maintenance Enzastaurin Following Whole Brain Radiation Therapy in the Treatment of Brain Metastases from Lung Cancer: The MENZA Study. European Journal of Cancer
    Abstract
  • Hatlen, Peter; Grønberg, Bjørn H.; Langhammer, Arnulf; Carlsen, Sven Magnus; Amundsen, Tore. (2011) Prolonged Survival in Patients with Lung Cancer with Diabetes Mellitus. Journal of Thoracic Oncology
    Academic article
  • Grønberg, Bjørn H.; Sundstrøm, Stein; Kaasa, Stein; Bremnes, Roy M.; Fløtten, Øystein; Amundsen, Tore. (2010) Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. European Journal of Cancer
    Academic article
  • Grønberg, Bjørn H.. (2010) ASCO Home Meetings Abstracts 2010 ASCO Annual Meeting Phase III study comparing vinorelbine/gemcitabine with vinorelbine/carboplatin as first-line chemotherapy of advanced NSCLC: A Norwegian Lung Cancer Study Group trial. Journal of Clinical Oncology
    Abstract
  • Grønberg, Bjørn H.. (2010) Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ). Journal of Clinical Oncology
    Abstract
  • Malmström, Annika; Poulsen, Hans Skovgaard; Stragliotto, G.; Grønberg, Bjørn H.; Hansen, S.; Asklund, Thomas. (2010) NEOADJUVANT TEMOZOLOMIDE FOR GRADE III AND IV ATROCYTOMA: A RANDOMIZED PHASE II STUDY. Neuro-Oncology
    Abstract
  • Malmström, Annika; Grønberg, Bjørn H.; Stupp, Roger; Marosi, Christine; Frappaz, Didier; Schultz, Henrik. (2010) GLIOBLASTOMA IN ELDERLY PATIENTS: HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN A RANDOMIZED TRIAL COMPARING 6-WEEKS OF RADIOTHERAPY (RT) VS HYPOFRACTIONATED RT OVER 2 WEEKS VS TEMOZOLOMIDE CHEMOTHERAPY (TMZ). Neuro-Oncology
    Abstract
  • Grønberg, BH; Bremnes, Roy M.; Aasebø, Ulf; Brunsvig, Paal; Fløtten, Øystein; Amundsen, T. (2009) A prospective phase II study: High-dose pemetrexed as second-line chemotherapy in small-cell lung cancer. Lung Cancer
    Academic article
  • Berger, Ola; Grønberg, Bjørn H.; Sand, Kari; Kaasa, Stein; Loge, Jon Håvard. (2009) The length of consent documents in oncological trials is doubled in twenty years. Annals of Oncology
    Academic article
  • Brunsvig, PF; Sundstrom, S; Aasebo, U; Bremnes, R; Hansen, O; Helle, SI. (2009) A phase III study of radiation therapy with concurrent docetaxel versus radiation therapy alone in patients with non-small cell lung cancer stage IIIA/B. Journal of Thoracic Oncology
    Abstract
  • Grønberg, BH; Gronberg, Bjørn H.; Bremnes, Roy M.; Fløtten, Øystein; Amundsen, T; Amundsen, Tore. (2009) Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology
    Academic article
  • Sand, Kari; Loge, Jon Håvard; Berger, Ola; Grønberg, Bjørn H.; Kaasa, Stein. (2008) Lung cancer patients' perceptions of informed consent documents. Patient Education and Counseling
    Academic article
  • Grønberg, Bjørn H.. (2007) Pemetrexed + carboplatin versus gemcitabine + carboplatin in the treatment of stage IIIB/IV non-small cell lung cancer. Journal of Clinical Oncology
    Abstract
  • Grønberg, Bjørn H.. (2007) A phase III study by the Norwegian Lung Cancer Group: Pemetrexed plus carboplatin vs. gemcitabine plus carboplatin as firstline chemotherapy in stage IIIB/IV non-small cell lung cancer. Journal of Thoracic Oncology
    Abstract

Part of book/report

  • Sundstrøm, Stein Harald; Brunsvig, Paal Fr.; Bremnes, Roy M.; Grønberg, Bjørn Henning; Brustugun, Odd Terje. (2016) Lungekreft. Universitetet i Oslo
    Chapter

Report

  • Grønberg, Bjørn H.; Mathisen, Cecilie Lund; Bjørkvoll, Marte. (2013) NTNU
    Thesis at a second degree level
  • Grønberg, Bjørn H.. (2010) Pemetrexed in the treatment of advanced lung cancer. Tapir Akademisk Forlag Tapir Akademisk Forlag
    Doctoral dissertation

INFORMASJONSMATR

  • Grønberg, Bjørn H.; Sørhaug, Sveinung. (2013)
    Website (informational material)

Media

2023

  • Interview
    Grønberg, Bjørn Henning. (2023) Norske sykehus ga 40.000 flere kreftkurer på poliklinikk i fjor enn for fem år siden: – Det blir travlere og travlere. Dagens medisin Dagens medisin [Internet] 2023-03-30
  • Interview
    Grønberg, Bjørn Henning. (2023) Bjørn Henning Grønberg fra St. Olavs hospital med viktig studie på ASCO om stråling av lungekreft. HealthTalk HealthTalk [Internet] 2023-06-05
  • Interview
    Grønberg, Bjørn Henning. (2023) Endret strålebehandlingen – nå er 40 prosent i live etter fem år. Dagens medisin Dagens medisin [Internet] 2023-06-02
  • Lecture
    Grønberg, Bjørn Henning. (2023) 5-years data: High-dose thoracic radiotherapy increase OS significant for patients with limited stage of small-cell lung cancer. Best Practice nordic MEDtalk , Online 2023-06-05 -
  • Interview
    Grønberg, Bjørn Henning. (2023) Adjuvans Tagrisso kan bli den nye standarden mot EGFR-mutert NSCLC. Onkologisk tidsskrift Onkologisk tidsskrift [Internet] 2023-06-07
  • Interview
    Grønberg, Bjørn Henning. (2023) Høydose stråling dobler nesten overlevelsen for pasienter med SCLC. Onkologisk tidsskrift Onkologisk tidsskrift [Journal] 2023-06-28
  • Poster
    Ottestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Dai, Hong Yan; Wahl, Sissel Gyrid Freim; Emdal, Elisabeth Fritzke. (2023) High tumor metabolic activity is associated with circulating tumor DNA detection in early-stage lung cancer patients. 13th International Symposium on Minimal Residual Cancer 2023-05-02 - 2023-05-04

2022

  • Lecture
    Grønberg, Bjørn Henning. (2022) From idea to results. Norwegian Cancer Precision Medicine Implementation Consortiu CONNECT seminar: investigator-initiated clinical trials , Digital 2022-10-24 - 2022-10-24
  • Poster
    Nøst, Therese Haugdahl; Urbarova, Ilona Halva; Skogholt, Anne Heidi; Mjelle, Robin; Paulsen, Erna Elise; Dønnem, Tom. (2022) Increased levels of mRNAs and miRNAs associated with imminent and advanced lung cancer. The International Association for the Study of Lung Cancer IASLC 2022 World Conference on Lung Cancer , Wien 2022-08-06 - 2022-08-09
  • Academic lecture
    Ottestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Sandvei, Marie Søfteland; Grønberg, Bjørn Henning. (2022) Association between ctDNA detection and tumor metabolic activity measured by PET/CT . Clinical implementation of liquid biopsy in the treatment of lung cancer 2022-11-10 - 2022-11-10

2021

  • Academic lecture
    Nøst, Therese Haugdahl; Skogholt, Anne Heidi; Mjelle, Robin; Grønberg, Bjørn Henning; Sandanger, Torkjel M; Sætrom, Pål. (2021) microRNA levels in serum at diagnosis are predictive for lung cancer. Kreftforeningen, Nasjonal ekspertgruppe for lungekreftforskning Forskningskonferansen for Kreftforeningens nasjonale ekspertgruppe for lungekreftforskning , Gardermoen 2021-08-26 - 2021-08-27
  • Poster
    Røyset, Inga Marie; Saltyte Benth, Jurate; Eriksen, Guro Falk; Saltvedt, Ingvild; Grønberg, Bjørn Henning; Rostoft, Siri . (2021) Edmonton Frail Scale predicts mortality in older patients with cancer undergoing radiotherapy - a prospective observational study. SIOG - International Society of Geriatric Oncology SIOG 2021 Virtual Annual Conference , Digital 2021-11-04 - 2021-11-05
  • Interview
    Grønberg, Bjørn Henning. (2021) Immunterapiene Yervoy og Keytruda i kombinasjon øker ikke overlevelsen - gir bare økte bivirkninger. healthtalk.no healthtalk.no [Internet] 2021-02-10

2020

  • Interview
    Grønberg, Bjørn Henning. (2020) Langt flere lungekreftpasienter overlever. Adresseavisen Adresseavisen [Newspaper] 2020-05-30
  • Interview
    Grønberg, Bjørn Henning. (2020) Dagens Medisin Dagens Medisin [Internet] 2020-05-29
  • Interview
    Grønberg, Bjørn Henning. (2020) Ny stråleterapi-studie kan endre behandlingen av lungekreft-pasienter. Dagens Medisin Dagens Medisin [Internet] 2020-05-28
  • Interview
    Grønberg, Bjørn Henning. (2020) Høy stråledose gir lungekreftpasienter 50 prosent økt overlevelse men ikke flere eller sterkere bivirkninger. healthtalk.no healthtalk.no [Internet] 2020-09-17
  • Interview
    Grønberg, Bjørn Henning. (2020) Tok "storeslem" med studie på lungekreft - la frem nye data. dagensmedisin.no dagensmedisin.no [Internet] 2020-09-19
  • Interview
    Grønberg, Bjørn Henning. (2020) Pandemien påvirker ikke oppfølgingen av lungekreftpasienter. Lungekreftforeningen Lungekreftforeningen [Internet] 2020-12-21
  • Interview
    Grønberg, Bjørn Henning. (2020) High-dose twice daily thoracic radiotherapy in limited disease small-cell lung cancer. ecancer.org ecancer.org [Internet] 2020-06-15
  • Interview
    Grønberg, Bjørn Henning. (2020) ESMO 2020: Standard-dose vs. high-dose thoracic radiotherapy in limited stage SCLC. vjoncology.com vjoncology.com [Internet] 2020-09-08
  • Interview
    Grønberg, Bjørn Henning. (2020) Best Practice Nordic Best Practice Nordic [Internet] 2020-09-29
  • Poster
    Ottestad, Anine Larsen; Emdal, Elisabeth Fritzke; Wahl, Sissel Gyrid Freim; Grønberg, Bjørn Henning; Dai, Hong Yan. (2020) Ultra-deep next-generation sequencing of selected single genes for detecting circulating tumor DNA in lung cancer patients. American Association for Cancer Research American Association for Cancer Research Annual Meeting 2020 2020-06-22 - 2020-06-24
  • Interview
    Grønberg, Bjørn Henning. (2020) Før ESMO: Den skandinaviske THORA-studien leger frem pasientrapporterte bivirkninger av høyere stråledose. healthtalk.no healthtalk.no [Internet] 2020-09-17
  • Interview
    Grønberg, Bjørn Henning. (2020) Lungekreftforeningen Facebook Lungekreftforeningen Facebook [Internet] 2020-02-18
  • Interview
    Grønberg, Bjørn Henning. (2020) Ny norsk studie: Lungekreftpasienter lever mye lengre med ny strålebehandlingsmetode. healthtalk.no healthtalk.no [Internet] 2020-05-26

2019

  • Interview
    Grønberg, Bjørn Henning. (2019) Lungekreftpasienter lever mye lenger med immunterapi - vil endre behandlingspraksis. healthtalk.no healthtalk.no [Internet] 2019-11-25
  • Interview
    Grønberg, Bjørn Henning. (2019) – Fire av fem alvorlig syke lungekreftpasienter får ikke den beste behandlingen. dagensmedisin.no dagensmedisin.no [Internet] 2019-03-10
  • Poster
    Ottestad, Anine Larsen; Dai, Hong Yan; Wahl, Sissel Gyrid Freim; Skorpen, Frank; Grønberg, Bjørn Henning. (2019) Large panel sequencing reveals heterogenous mutation pattern in tumor tissue and circulating tumor DNA. Nosk Biokjemisk Selskap Norsk Biokjemisk Selskap Kontaktmøte 2019 , Røros 2019-01-24 - 2019-01-27
  • Interview
    Grønberg, Bjørn Henning. (2019) NRK NRK [Radio] 2019-03-25
  • Interview
    Grønberg, Bjørn Henning. (2019) NRK NRK [Radio] 2019-03-12
  • Interview
    Grønberg, Bjørn Henning. (2019) Dagens Medisin Dagens Medisin [Internet] 2019-06-03
  • Interview
    Grønberg, Bjørn Henning. (2019) Dagens Medisin Dagens Medisin [Internet] 2019-06-02
  • Interview
    Grønberg, Bjørn Henning. (2019) VG VG [Newspaper] 2019-06-03
  • Interview
    Grønberg, Bjørn Henning. (2019) Dagens Medisin Dagens Medisin [Internet] 2019-06-02
  • Poster
    Skogholt, Anne Heidi; Jensen, Espen Drevland; Ryeng, Einar; Grønberg, Bjørn Henning; Skorpen, Frank; Schønberg, Svanhild Margrethe Arentz. (2019) Robust messenger RNA (mRNA) markers in blood for lung cancer diagnosis. ASHG , Houston 2019-10-18 - 2019-10-18
  • Interview
    Grønberg, Bjørn Henning. (2019) - På vei mot ny type lungekreftbehandling. lungekreftforeningen.no lungekreftforeningen.no [Internet] 2019-12-01
  • Poster
    Wahl, Sissel Gyrid Freim; Dai, Hong Yan; Emdal, Elisabeth Fritzke; Ottestad, Anine Larsen; Richardsen, Elin; Halvorsen, Tarje Onsøien. (2019) Prognostic value of mutated KRAS in circulating tumor DNA prior to therapy in patients with lung cancer. IASLC World Conference on Lung Cancer 2019 , Barcelona 2019-09-07 - 2019-09-10
  • Poster
    Pettersen, Kristine; Andersen, Sonja Benedikte; Tadini, Valentina; Hatakeyama, Shinji; Nonstad, Unni; Grønberg, Bjørn Henning. (2019) IL-6 secreted from cancer cells induce autophagy and cancer cachexia. Conference on Molecular Mechanisms of Inflammation 2019 2019-06-03 - 2019-06-06
  • Poster
    Pettersen, Kristine; Andersen, Sonja Benedikte; van der Veen, Anna; Nonstad, Unni; Hatakeyama, Shinji; Lambert, Christian. (2019) Autocrine activin A signaling regulates secretion of interleukin 6, autophagy, and cachexia. The 12th international conference on Cachexia, Sarcopenia and Muscle Wasting 2019-12-06 - 2019-12-08
  • Interview
    Grønberg, Bjørn Henning. (2019) Lungekreftprofessor advarer Stortinget: - Tenk dere om før dere sier ja til e-sigaretter. healthtalk.no healthtalk.no [Internet] 2019-11-17
  • Programme participation
    Grønberg, Bjørn Henning. (2019) dagensmedisin.no dagensmedisin.no [Internet] 2019-06-03
  • Lecture
    Grønberg, Bjørn Henning. (2019) Dagens Medisin DM Arena-møte , Radiumhospitalet, Oslo 2019-06-11 - 2019-06-11
  • Lecture
    Grønberg, Bjørn Henning. (2019) Lungekreftforeningen Lungekreftkonferansen , Oslo 2019-11-11 - 2019-11-11
  • Poster
    Stokke, Kristin; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Sørhaug, Sveinung; Madebo, Tesfaye; Raj, Sunil Xavier. (2019) Randomized phase III trial comparing maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Verdenskonferansen for lungekreft, WCLC , Barcelona 2019-09-07 - 2019-09-10

2018

  • Poster
    Kristensen, Are Korsnes; Solheim, Tora Skeidsvoll; Fløtten, Øystein; Grønberg, Bjørn Henning. (2018) Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small- cell lung cancer. ESMO ESMO congress 2018 , Munchen 2018-10-19 - 2018-10-23

2016

  • Poster
    Kirkhus, Lene; Saltyte Benth, Jurate; Rostoft, Siri; Grønberg, Bjørn Henning; Hjermstad, Marianne Jensen; Selbæk, Geir. (2016) P111 "Frailty and survival in old patients with cancer; clinical judgment and systematic geriatric assessments" JGO Volume 7/6 Supplement 1 Nov 16 S131-132. International Society of Geriatric Oncology Annual Conference 2016 , Milano 2016-11-17 - 2016-11-19
  • Poster
    Pettersen, Kristine; Andersen, Sonja Benedikte; Moestue, Siver Andreas; Nonstad, Unni; Romundstad, Pål Richard; Skorpen, Frank. (2016) Tumor-derived IL-6 contributes to cancer cachexia by increasing autophagy. Conference on Molecular mechanisms of inflammation 2016-05-30 - 2016-06-02

2015

  • Poster
    Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf. (2015) Association between comorbidity, treatment toxicity and overall survival in limited disease small-cell lung cancer. International Association for the study of Lung Cancer 16TH WORLD CONFERENCE ON LUNG CANCER , Denver, Colorado 2015-09-06 - 2015-09-09
  • Academic lecture
    Kaasa, Stein; Vagnildhaug, Ola Magne; Grønberg, Bjørn Henning; Solheim, Tora Skeidsvoll. (2015) Relevance of poor performance status in oncology. European School of Oncology Cachexia and nutrition in advanced cancer patients: A multidisciplinary approach , Barcelona 2015-03-13 - 2105-03-14
  • Poster
    Kristensen, Are Korsnes; Vagnildhaug, Ola Magne; Grønberg, Bjørn Henning; Kaasa, Stein; Laird, Barry J.; Solheim, Tora Skeidsvoll. (2015) Does chemotherapy improve quality of life in advanced pancreatic cancer? A systematic review. EAPC 14th Congress of the European Association for Palliative Care , København 2015-10-08 - 2015-10-10
  • Poster
    Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Levin, Nina; Bremnes, Roy M.; Brunsvig, Paal Fr.; Brustugun, Odd Terje. (2015) Survival of patients with N3 lymph node disease in a cohort with limited disease small-cell lung cancer receiving concurrent chemoradiotherapy. International Association for the study of Lung Cancer 16TH WORLD CONFERENCE ON LUNG CANCER , Denver, Colorado 2015-09-06 - 2015-09-09

2014

  • Poster
    Grønberg, Bjørn H.; Bjørkvoll, Marte; Mathisen, Cecilie Lund; Lund, Jo-Åsmund; Kaasa, Stein. (2014) Causes for hospitalizing patients at a university hospital cancer clinic. American Society of Clinical Oncology ASCO Annual Meeting 2014 , Chicago 2014-05-31 - 2014-06-03
  • Academic lecture
    Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Balstad, Trude Rakel; Sjøblom, Bjørg; Jordhøy, Marit; Solheim, Tora Skeidsvoll. (2014) The prognostic value of comorbidity and body muscle mass in patient with advanced non-small-cell lung cancer. European Association of Palliative Care 4th International Seminar of the PRC and EAPC RN , Amsterdam 2014-10-16 - 2014-10-17
  • Interview
    Kringstad, Kirsti; Grønberg, Bjørn H.; Sørhaug, Sveinung. (2014) Slik vil de forlenge livet til kreftsyke. http://www.adressa.no/pluss/nyheter/article10086364.ece http://www.adressa.no/pluss/nyheter/article10086364.ece [Internet] 2014-09-03
  • Interview
    Kringstad, Kirsti; Grønberg, Bjørn H.; Sørhaug, Sveinung. (2014) Adresseavisen Adresseavisen [Newspaper] 2014-09-04
  • Interview
    Kringstad, Kirsti; Fugelli, Per; Grønberg, Bjørn H.. (2014) http://www.adressa.no/pluss/nyheter/article10094890.ece http://www.adressa.no/pluss/nyheter/article10094890.ece [Internet] 2014-09-05
  • Interview
    Kringstad, Kirsti; Grønberg, Bjørn H.; Fugelli, Per. (2014) Adresseavsen Adresseavsen [Newspaper] 2014-09-06
  • Interview
    Bordvik, Målfrid; Grønberg, Bjørn H.. (2014) http://www.dagensmedisin.no/asco2014/flere-reinnleggelser-et http://www.dagensmedisin.no/asco2014/flere-reinnleggelser-et [Internet] 2014-05-29
  • Interview
    Bordvik, Målfrid; Grønberg, Bjørn H.; Sørhaug, Sveinung. (2014) http://www.dagensmedisin.no/nyheter/gar-i-gang-med-stor-nors http://www.dagensmedisin.no/nyheter/gar-i-gang-med-stor-nors [Internet] 2014-06-18
  • Academic lecture
    Berger, Ola; Sand, Kari; Johansen, Ingunn; Kaasa, Stein; Loge, Jon Håvard; Grønberg, Bjørn Henning. (2014) What Do Cancer Patients and Members of Ethical Review Boards in Norway Consider Important Elements in Informed Consent Documents?. European Association for Palliative Care (EAPC) 8th World Research Congress of the European Association for Palliative Care (EAPC) , Lleida 2014-06-05 - 2014-06-07

2013

  • Poster
    Pettersen, Kristine; Andersen, Sonja Benedikte; Moestue, Siver Andreas; Tesfahun, Almaz Nigatu; Sørhaug, Sveinung; Amundsen, Tore. (2013) Systemically accelerated autophagy causal in cancer cachexia?. Seventh cachexia conference 2013-12-09 - 2013-12-11
  • Interview
    Fugelsnes, Elin; Grønberg, Bjørn H.. (2013) Forskningsrådet Forskningsrådet [Internet] 2013-10-03
  • Poster
    Grønberg, Bjørn Henning; Sørhaug, Sveinung; Hjelde, Harald Harris; Amundsen, Tore. (2013) Variation in health related quality of life (HRQoL) during chemotherapy for advanced non-small-cell lung cancer (NSCLC). ASCO ASCO American Society of Clinical Oncology , Chicago 2013-05-31 - 2013-06-04

2012

  • Academic lecture
    Anshushaug, Malin; Gynnild, Mari Aas; Kaasa, Stein; Kvikstad, Anne; Grønberg, Bjørn Henning. (2012) Palliative cancer therapy during end-of-life at St.Olavs Hospital – Trondheim University Hospital, Norway. European Assocation of Palliative Care 7th World Research Congress of the EAPC , Trondheim 2012-06-06 - 2012-06-09
  • Poster
    Gynnild, Mari Aas; Anshushaug, Malin; Kvikstad, Anne; Kaasa, Stein; Grønberg, Bjørn Henning. (2012) Use of palliative cancer therapy during End-of-life at St. Olavs Hospital, Trondheim, Norway. American Society of Clinical Oncology ASCO Annual Meeting 2012 , Chicago 2012-06-01 - 2012-06-05
  • Poster
    Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf. (2012) Phase II Trial Comparing Two Schedules of Thoracic Radiotherapy in Limited Disease Small-Cell Lung Cancer. American Society of Clinical Oncology ASCO Annual Meeting 2012 , Chicago 2012-06-01 - 2012-06-05
  • Poster
    Hatlen, Peter; Langhammer, Arnulf; Forsmo, Siri; Grønberg, Bjørn Henning; Carlsen, Sven Magnus; Amundsen, Tore. (2012) Osteoporosis and risk of NSCLC, the HUNT study. ERS Eur Resp Society ERS Wien 2012 , Wien 2012-09-01 - 2012-09-05

2011

  • Poster
    Grønberg, Bjørn Henning; Lund-Iversen, Marius; Strøm, Erik Heyerdahl; Brustugun, Odd Terje; Scott, Helge. (2011) Associations between biomarkers and outcomes of first-line chemotherapy in advanced non-small cell lung cancer (NSCLC). American Society of Clinical Oncology ASCO Annual Meeting 2011 , Chicago 2011-06-03 - 2011-06-07
  • Poster
    Grønberg, Bjørn Henning; Ciuleanu, Tudor; Fløtten, Øystein; Knuutila, Aija; Abel, Edvard; Langer, Seppo. (2011) Randomized Phase Study of Maintenance Enzastaurin Following Whole Brain Radiation Therapy in the Treatment of Brain Metastases from Lung Cancer: The MENZA Study. European Society for Medical Oncology The European Multidisciplinary Cancer Congress ECCO 16 , Stockholm 2011-09-24 - 2011-09-27
  • Poster
    Hatlen, Peter; Grønberg, Bjørn Henning; Langhammer, Arnulf; Carlsen, Sven Magnus; Amundsen, Tore. (2011) Prolonged survival in lung cancer patients with diabetes mellitus: a large cohort study. ERS Eur Resp Society ERS 2011 Amsterdam , Amsterdam 2011-09-24 - 2011-09-28

2010

  • Poster
    Grønberg, Bjørn H.. (2010) NEOADJUVANT TEMOZOLOMIDE FOR GRADE III AND IV ATROCYTOMA: A RANDOMIZED PHASE II STUDY. European Association of NeuroOncology 9th Meeting of the European Association of NeuroOncology , Maastricht 2010-09-16 - 2010-10-19
  • Academic lecture
    Grønberg, Bjørn H.. (2010) GLIOBLASTOMA IN ELDERLY PATIENTS: HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN A RANDOMIZED TRIAL COMPARING 6-WEEKS OF RADIOTHERAPY (RT) VS HYPOFRACTIONATED RT OVER 2 WEEKS VS TEMOZOLOMIDE CHEMOTHERAPY (TMZ). European Association of NeuroOncology 9th Meeting of the European Association of NeuroOncology , Maastricht 2010-09-16 - 2010-10-19
  • Poster
    Grønberg, Bjørn H.. (2010) Phase III study comparing vinorelbine/gemcitabine with vinorelbine/carboplatin as first-line chemotherapy of advanced NSCLC: A Norwegian Lung Cancer Study Group trial. American Society of Clinical Oncology ASCO Annual meeting 2010 , Chicago 2010-06-05 - 2010-06-08
  • Academic lecture
    Grønberg, Bjørn H.. (2010) Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ). American Society of Clinical Oncology ASCO Annual Meeting 2010 , Chicago 2010-06-05 - 2010-06-08
  • Poster
    Fløtten, Øystein; Bremnes, Roy M.; Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Amundsen, Tore; Rolke, Heidi. (2010) Phase III study comparing vinorelbine-gemcitabine with vinorelbine-carboplatin as first-line chemotherapy of advanced NSCLC: A Norwegian Lung Cancer Study Group trial. ASCO ASCO , Chicago 2010-06-04 - 2010-06-08
  • Poster
    Fløtten, Øystein; Bremnes, Roy M.; Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Amundsen, Tore; Rolke, Heidi. (2010) Phase III study comparing vinorelbine-gemcitabine with vinorelbine-carboplatin as first-line chemotherapy of advanced NSCLC: A Norwegian Lung Cancer Study Group trial. ASCO ASCO Annual meeting , Chicago 2010-06-04 - 2010-06-08

2008

  • Academic lecture
    Grønberg, Bjørn H.. (2008) Onkologisk Forum Onkologisk Forum , Bergen 2008-11-20 - 2008-11-21
  • Academic lecture
    Grønberg, Bjørn H.. (2008) The prognostic value of comorbidity assessed using the Cumulative Illness Rating Scale for Geriatrics (CIRS-G) in patients with advanced non-small cell lung cancer (NSCLC). ASCO ASCO Annual Meeting 2008 , Chicago 2008-05-31 - 2008-06-03
  • Poster
    Sand, Kari; Loge, Jon Håvard; Berger, Ola; Grønberg, Bjørn H.; Kaasa, Stein. (2008) Consent documents for a palliative chemotherapy trial – what do the patients actually perceive?. Institutt for språk- og kommunikasjonsstudier Faglig og sosialt nettverksmøte ved Institutt for språk- og kommunikasjonsstudier , Trondheim 2008-12-06 - 2008-12-06
  • Poster
    Sand, Kari; Loge, Jon Håvard; Berger, Ola; Grønberg, Bjørn H.; Kaasa, Stein. (2008) Consent documents for a palliative chemotherapy trial – what do the patients actually perceive?. European Association for Palliative Care 5th Research Forum of the EAPC , Trondheim 2008-05-29 - 2008-05-31

2007

  • Academic lecture
    Grønberg, Bjørn H.. (2007) Pemetrexed + carboplatin versus gemcitabine + carboplatin in the treatment of stage IIIB/IV non-small cell lung cancer. American Society of Clinical Oncology ASCO Annual meeting 2007 , Chicago 2007-05-31 - 2007-06-05
  • Academic lecture
    Grønberg, Bjørn H.. (2007) A phase III study by the Norwegian Lung Cancer Group: Pemetrexed + carboplatin vs. gemcitabine + carboplatin as first-line chemotherapy in stage IIIB/IV non-small cell lung cancer. International Association for the Study of Lung Cancer 12th World Conference on Lung Cancer , Seoul 2007-09-02 - 2007-09-06
NTNU
Studies
  • Master's programmes in English
  • For exchange students
  • PhD opportunities
  • Courses
  • Career development
  • Continuing education
  • Application process
Contact
  • Contact NTNU
  • Employees
  • For alumni
  • Press contacts
  • Researcher support
Discover NTNU
  • Experts
  • Vacancies
  • Pictures from NTNU
  • Innovation resources
  • NTNU in Gjøvik
  • NTNU in Trondheim
  • NTNU in Ålesund
  • Maps
About NTNU
  • NTNU's strategy
  • Research excellence
  • Strategic research areas
  • Organizational chart
  • Libraries
  • About the university
Services
  • For employees
  • For students
  • Blackboard
  • Intranet

Norwegian University of Science and Technology

Use of cookies
Accessibility statement (in Norwegian)
Privacy policy
Editorial responsibility
Sign In